Literature DB >> 2838626

Kinetic and equilibrium studies of (-)125iodocyanopindolol binding to beta-adrenoceptors on human lymphocytes: evidence for the existence of two classes of binding sites.

T Anhäupl1, B Liebl, J Remien.   

Abstract

Saturation experiments were performed on intact human peripheral mononuclear leucocytes (MNL) and MNL membranes with (-)125Iodocyanopindolol (125ICYP) over a large concentration range (1.5-600 pmol/l). The corresponding Scatchard plots were curvilinear suggesting two saturable classes of binding sites: A high affinity binding site (Bmax1 = 1000 +/- 400 sites/cell, Kd1 = 2.1 +/- 0.9 pmol/l for intact MNL and Bmax1 = 550 +/- 190 sites/cell, Kd1 = 4.1 +/- 0.9 pmol/l for MNL membranes) and a low affinity binding site (Bmax2 = 9150 +/- 3590 binding sites/cell, Kd2 = 440 +/- 50 pmol/l for intact MNL and Bmax2 = 11560 +/- 4690 sites/cell, Kd2 = 410 +/- 70 pmol/l for MNL membranes). Dissociation of (-)125ICYP from MNL was biphasic consisting of a slow dissociating component (dissociation rate constant k-1 = (0.5 +/- 0.2) X 10(-3) min-1 for intact MNL and k-1 = (1.0 +/- 0.1) X 10(-3) min-1 for MNL membranes) and a fast dissociating component (k-2 = (80 +/- 20) X 10(-3) min-1 for intact MNL and k-2 = (60 +/- 10) X 10(-3) min-1 for MNL membranes). In dissociation experiments started after equilibration with various (-)125ICYP concentrations k-1 and k-2 were independent of the equilibrium concentration, whereas the percentual occupancy of the slow and the fast dissociating component varied and was similar to the estimated fractional occupancy of either binding site at the same (-)125ICYP concentrations in saturation experiments. The association rate constant was in the same order of magnitude for both binding sites. These results suggest two independent classes of binding sites for (-)125ICYP on MNL.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2838626     DOI: 10.3109/10799898809048977

Source DB:  PubMed          Journal:  J Recept Res        ISSN: 0197-5110


  5 in total

1.  Analysis of ligand-receptor interactions from the molecular level to the whole-body level.

Authors:  B N Manukhin
Journal:  Neurosci Behav Physiol       Date:  2002 May-Jun

2.  Reovirus type 3 binds to antagonist domains of the beta-adrenergic receptor.

Authors:  S T Donta; J D Shanley
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

3.  Beta-adrenergic blood pressure regulation in Shy-Drager syndrome and pheochromocytoma.

Authors:  M Middeke; J Ittner; M Mezger; S Reder; J Remien
Journal:  Klin Wochenschr       Date:  1989-10-02

4.  Circannual variation in the expression of beta 2-adrenoceptors on human peripheral mononuclear leukocytes (MNLs).

Authors:  E Haen; I Langenmayer; A Pangerl; B Liebl; J Remien
Journal:  Klin Wochenschr       Date:  1988-07-01

5.  Effect of thiols on beta 2-adrenoceptors in human mononuclear leucocytes.

Authors:  B Liebl; T Anhäupl; E Haen; J Remien
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-11       Impact factor: 3.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.